HOME HOME is an global initiative of patients, healthcare professionals, journal editors, regulatory authorities and the pharmaceutical industry. Aim: To develop a consensus-based core outcome set (COS) for clinical trials and clinical practice.The core outcome set is the MINIMUM that should be measured in ALL clinical trials. HOME Core Outcome Set (for clinical trials) Clinical signs (Core Outcome Instrument: EASI) Symptoms (Core Outcome Instrument: POEM) Long term control Quality of Life
HOME is an global initiative of patients, healthcare professionals, journal editors, regulatory authorities and the pharmaceutical industry.
Aim: To develop a consensus-based core outcome set (COS) for clinical trials and clinical practice.The core outcome set is the MINIMUM that should be measured in ALL clinical trials.
Membership of HOME is free and open to anyone with an interest in atopic eczema outcomes.
The next HOME meeting will be Wednesday 11 April 2018, 09:00-12:00 (satellite to the ISAD 2018 in Utrecht, The Netherlands). The focus will be on identifying valid and feasible outcome measurement instruments for atopic eczema in routine clinical practice. See our HOME VI meeting page for further information.
Centre of Evidence Based Dermatology University of Nottingham King's Meadow Campus Lenton Lane, Nottingham NG7 2NR, UK
Telephone: +44 115 8232435 Fax: +44 115 8468618 Email: HOME@nottingham.ac.uk
Browser does not support script.